Advanzeon Solutions, Inc. (CHCR) Análisis de Acciones
Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Advanzeon Solutions, Inc. (CHCR) opera en el sector Healthcare, cotizado por última vez a $ con una capitalización de mercado de 0. Calificado con 46/100 (cauteloso) en potencial de crecimiento, salud financiera e impulso.
Ultimo analisis: 16 mar 2026Advanzeon Solutions, Inc. (CHCR) Resumen de Asistencia Médica y Tuberías
Advanzeon Solutions, Inc. operates in the healthcare sector, focusing on sleep apnea program administration through its SleepMaster Solutions. Currently trading on the OTC market after a Chapter 11 filing, the company faces challenges in a competitive medical care facilities landscape.
Tesis de Inversión
Investing in Advanzeon Solutions, Inc. (CHCR) presents significant risks due to its OTC market listing and recent Chapter 11 bankruptcy filing in 2020. The company's reliance on the SleepMaster Solutions program for revenue makes it vulnerable to market shifts and competition. With a market capitalization of $0.00B and a beta of 1.24, CHCR exhibits high volatility. Potential investors should closely monitor the company's restructuring efforts and ability to regain financial stability. Growth catalysts are uncertain, and the company's future depends on successfully navigating its bankruptcy proceedings and re-establishing a competitive position in the healthcare sector.
Basado en las finanzas de FMP y el análisis cuantitativo
Puntos clave
- Advanzeon Solutions, Inc. operates the SleepMaster Solutions sleep apnea program.
- The company filed for Chapter 11 bankruptcy on September 7, 2020.
- CHCR trades on the OTC market, indicating higher risk and lower liquidity.
- The company's market capitalization is $0.00B, reflecting its distressed financial state.
- The company's beta is 1.24, indicating higher volatility than the market.
Competidores y Pares
Fortalezas
- Specialized SleepMaster Solutions program.
- Experience in sleep apnea program administration.
- Established presence in the healthcare sector.
- Focus on a specific medical condition.
Debilidades
- Recent Chapter 11 bankruptcy filing.
- OTC market listing indicating higher risk.
- Limited market capitalization.
- Reliance on a single product line.
Catalizadores
- Upcoming: Successful restructuring and emergence from Chapter 11 bankruptcy could restore investor confidence.
- Ongoing: Expansion of the SleepMaster Solutions program into new markets could drive revenue growth.
- Ongoing: Strategic partnerships with healthcare providers could enhance market penetration.
Riesgos
- Ongoing: Financial instability due to Chapter 11 bankruptcy.
- Potential: Intense competition in the medical care facilities industry.
- Potential: Regulatory changes and reimbursement pressures.
- Ongoing: Limited liquidity and high volatility due to OTC market listing.
- Potential: Dependence on a single product line (SleepMaster Solutions).
Oportunidades de crecimiento
- Expansion of Sleep Apnea Program: Advanzeon could focus on expanding its SleepMaster Solutions program by targeting new geographic markets and patient demographics. The global sleep apnea devices market is projected to reach $5.2 billion by 2027, offering a substantial growth opportunity. Success depends on effective marketing, strategic partnerships, and demonstrating superior patient outcomes.
- Telehealth Integration: Integrating telehealth services into the SleepMaster Solutions program could enhance accessibility and convenience for patients, particularly in remote areas. The telehealth market is experiencing rapid growth, driven by technological advancements and increasing demand for remote healthcare solutions. This integration could improve patient engagement and reduce operational costs.
- Strategic Partnerships: Forming strategic alliances with healthcare providers, insurance companies, and sleep clinics could expand Advanzeon's reach and market penetration. Partnerships can provide access to new patient referrals, distribution channels, and reimbursement opportunities. Successful partnerships require alignment of goals, clear communication, and mutual benefit.
- Product Diversification: Diversifying beyond sleep apnea treatment into related respiratory care services could broaden Advanzeon's revenue streams and reduce its reliance on a single product line. This could include offering diagnostic services, respiratory therapy, and home healthcare solutions. Diversification requires careful market research, investment in new technologies, and skilled personnel.
- Cost Optimization: Implementing cost-saving measures and streamlining operations could improve Advanzeon's financial performance and enhance its competitiveness. This includes optimizing supply chain management, reducing administrative expenses, and improving operational efficiency. Cost optimization is crucial for companies facing financial challenges and can improve profitability and cash flow.
Oportunidades
- Expansion into new geographic markets.
- Integration of telehealth services.
- Strategic partnerships with healthcare providers.
- Diversification into related respiratory care services.
Amenazas
- Intense competition in the medical care facilities industry.
- Regulatory changes and reimbursement pressures.
- Potential for product obsolescence.
- Economic downturn affecting patient affordability.
Ventajas competitivas
- Proprietary SleepMaster Solutions program.
- Established relationships with healthcare providers.
- Experience in sleep apnea program administration.
- Focus on specialized care services.
Acerca de CHCR
Advanzeon Solutions, Inc., formerly known as Comprehensive Care Corporation, was established in 1969 and rebranded in January 2014. Headquartered in Tampa, Florida, the company operates through its subsidiary, Pharmacy Value Management Solutions, Inc., which administers and manages the SleepMaster Solutions program, a sleep apnea treatment service. Advanzeon's core business revolves around providing solutions for individuals suffering from sleep apnea, a prevalent condition affecting millions. However, on September 7, 2020, Advanzeon Solutions, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Middle District of Florida, impacting its operational and financial stability. The company's long-term viability hinges on its ability to restructure and regain market confidence while navigating the competitive landscape of the medical care facilities industry.
Qué hacen
- Administers and operates the SleepMaster Solutions sleep apnea program.
- Provides solutions for individuals suffering from sleep apnea.
- Operates through its subsidiary, Pharmacy Value Management Solutions, Inc.
- Offers sleep apnea treatment services.
- Focuses on managing sleep apnea programs.
- Aims to improve the quality of life for sleep apnea patients.
Modelo de Negocio
- Generates revenue through the SleepMaster Solutions program.
- Provides sleep apnea treatment services to patients.
- Partners with healthcare providers and insurance companies.
- Focuses on program administration and management.
Contexto de la Industria
Advanzeon Solutions, Inc. operates within the medical care facilities industry, a segment of the broader healthcare sector. This industry is characterized by increasing demand for specialized care services, including sleep apnea treatment. However, the competitive landscape is intense, with established players and emerging technologies vying for market share. Advanzeon's position is challenged by its recent bankruptcy filing and the need to restructure its operations. The industry is also subject to regulatory changes and reimbursement pressures, further impacting the company's prospects.
Clientes Clave
- Individuals suffering from sleep apnea.
- Healthcare providers and sleep clinics.
- Insurance companies covering sleep apnea treatment.
- Patients seeking solutions for sleep-related breathing disorders.
Finanzas
Gráfico e información
Precio de la acción de Advanzeon Solutions, Inc. (CHCR): Price data unavailable
Últimas noticias
No hay noticias recientes disponibles para CHCR.
Consenso de analistas
Calificación de Consenso
Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para CHCR.
Objetivos de Precios
Análisis del precio objetivo de Wall Street para CHCR.
MoonshotScore
¿Qué significa esta puntuación?
El MoonshotScore califica el potencial de crecimiento de CHCR en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.
Liderazgo: Clark A. Marcus
Managing Director
Clark A. Marcus serves as the Managing Director of Advanzeon Solutions, Inc. His role involves overseeing the company's operations and strategic direction. Information on his prior experience and education is not available. As the managing director, he is responsible for the overall performance and management of the company, particularly during its restructuring phase following the Chapter 11 filing.
Historial: Due to limited information available, Clark A. Marcus's specific achievements and strategic decisions at Advanzeon Solutions, Inc. are unknown. His tenure is marked by the company's Chapter 11 bankruptcy filing in 2020, indicating significant challenges during his leadership. Evaluating his long-term impact requires further information on the company's restructuring efforts and future performance.
Información del mercado OTC de CHCR
The OTC Other tier represents the lowest tier of the OTC market, indicating that Advanzeon Solutions, Inc. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier often have limited reporting requirements and may be undergoing financial distress or restructuring. Unlike NYSE or NASDAQ-listed companies, OTC Other stocks generally have less stringent listing requirements, leading to increased risk and volatility for investors. This tier signifies a higher level of caution is warranted due to the potential for limited information and regulatory oversight.
- Nivel OTC: OTC Other
- Estado de divulgación: Unknown
- Limited financial disclosure due to OTC Other listing.
- High price volatility and potential for manipulation.
- Risk of delisting or trading suspension.
- Limited liquidity and wide bid-ask spreads.
- Potential for fraud or mismanagement.
- Verify the company's financial statements and SEC filings (if any).
- Assess the company's management team and their track record.
- Evaluate the company's business model and competitive landscape.
- Review the company's legal and regulatory compliance.
- Analyze the company's debt and cash flow situation.
- Monitor news and press releases for updates on the company's restructuring efforts.
- Consult with a financial advisor before investing.
- Established history since 1969.
- Operation of the SleepMaster Solutions program.
- Presence in the healthcare sector.
- Continued efforts to restructure after bankruptcy.
- Existence of a subsidiary, Pharmacy Value Management Solutions, Inc.
Preguntas Comunes Sobre CHCR
¿Cuáles son los factores clave para evaluar CHCR?
Advanzeon Solutions, Inc. (CHCR) actualmente tiene una puntuación IA de 46/100, indicando puntuación baja. Fortaleza clave: Specialized SleepMaster Solutions program.. Riesgo principal a monitorear: Ongoing: Financial instability due to Chapter 11 bankruptcy.. Esto no es asesoramiento financiero.
¿Qué es el MoonshotScore de CHCR?
CHCR actualmente puntúa 46/100 (Grado D) en el MoonshotScore, lo que sugiere calificación baja. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.
¿Con qué frecuencia se actualizan los datos de CHCR?
Los precios de CHCR se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.
¿Qué dicen los analistas sobre CHCR?
La cobertura de analistas para CHCR incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.
¿Cuáles son los riesgos de invertir en CHCR?
Las categorías de riesgo para CHCR incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Financial instability due to Chapter 11 bankruptcy.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.
¿Cuál es la relación P/E de CHCR?
La relación P/E para CHCR compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.
¿Está CHCR sobrevalorada o infravalorada?
Determinar si Advanzeon Solutions, Inc. (CHCR) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.
¿Cuál es el rendimiento por dividendo de CHCR?
Advanzeon Solutions, Inc. (CHCR) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.
Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.
Recursos Oficiales
Datos proporcionados solo con fines informativos.
- Information is limited due to the company's OTC listing and bankruptcy filing.
- Financial data may not be readily available or reliable.
- Analyst coverage is unlikely given the company's financial condition.